10,000
Participants
Start Date
August 1, 2021
Primary Completion Date
June 30, 2024
Study Completion Date
December 31, 2025
Mirvie Predictive Test for Adverse Pregnancy Outcomes
This is a proprietary biomarker and clinical factor-based algorithm for predicting which pregnancies are at greatest risk of developing a variety of adverse pregnancy outcomes (e.g., preterm birth, preeclampsia)
University of Pittsburgh Medical Center, Pittsburgh
Thomas Jefferson University, Philadelphia
Women's Care Florida, Orlando
The Ohio State University, Columbus
Washington University School of Medicine, St Louis
Ochsner Health System, New Orleans
University of Texas Medical Branch, Galveston
University of California San Diego, San Diego
MultiCare, Tacoma
Beth Israel Deaconess Medical Center, Boston
Lead Sponsor
Mirvie
INDUSTRY